GlaxoSmithKline PLC Common Stock (GSK): Rumor News

GSK – The Evening Standard discusses market rumors that Gilead & GlaxoSmithKlein may be eyeing United Therapeutics.


Key Facts Surrounding This News Item


  • GSK had a POWR Rating of B (Buy) coming into today.
  • GSK was -1.23% below its 10-Day Moving Average coming into today.
  • GSK was -2.67% below its 20-Day Moving Average coming into today.
  • GSK was -5.04% below its 50-Day Moving Average coming into today.
  • GSK was -3.66% below its 100-Day Moving Average coming into today.
  • GSK was 0.81% above its 200-Day Moving Average coming into today.
  • GSK had returned +8.38% year-to-date leading up to today’s news, versus a +11.50% return from the benchmark S&P 500 during the same period.

More Info About GlaxoSmithKline PLC Common Stock (GSK)


GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company’s wellness products include Panadol and Panadol Cold & Flu, ENO and Tums Рantacids, and Nicorette (US), Nicoderm, NiQuitin CQ, and Nicabate Рtreatment of nicotine withdrawal, Sensodyne Рto ttreat and prevent dental sensitivity, Polident, Poligrip, and Corega to enhance comfort of fitted denture, and Aquafresh for the prevention of gum disease and bad breath. The company was founded in 1935 and is based, the United Kingdom. View our full GSK ticker page with ratings, news, and more.

GSK at a Glance

GSK Current POWR Rating™
Overall POWR Rating™
GSK Current Price $38.70 0.13%
More GSK Ratings, Data, and News

GSK Price Reaction

The day of this event (Aug. 4, 2017)
GSK Closing Price$40.03 0.39%
GSK Volume2,506,856
23.83% from avg
Leading up to this event
GSK 1-mo returnN/A%
After this event
GSK 1-day return0.97%
GSK 3-day return1.68%
GSK 5-day return3.62%

GSK Price Chart



More GlaxoSmithKline PLC Common Stock (GSK) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All GSK News
Page generated in 4.4026 seconds.